IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 26
Titolo Data di pubblicazione Autore(i) File
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 1-gen-2019 Kozakova, J.; Altay, A.; Zdimal, V.; Maskova, L.; Sonvico, F.; Quarta, Eride; Rossi, A.; Buttini, F.; Colombo, G.
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 1-gen-2020 Quarta, Eride; Chierici, Veronica; Flammini, Lisa; Tognolini, Massimiliano; Barocelli, Elisabetta; Cantoni, Anna Maria; Dujovny, Gabriela; Ecenarro Probst, Susana; Sonvico, Fabio; Colombo, Gaia; Rossi, Alessandra; Bettini, Ruggero; Colombo, Paolo; Buttini, Francesca
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 1-gen-2020 Chierici, Veronica; Cavalieri, Luca; Piraino, Alessio; Paleari, Davide; Quarta, Eride; Sonvico, Fabio; Melani, Andrea S; Buttini, Francesca
Calcium phosphate nanoparticle precipitation by a continuous flow process: A design of an experiment approach 1-gen-2020 Esposti, L. D.; Dotti, A.; Adamiano, A.; Fabbi, C.; Quarta, E.; Colombo, P.; Catalucci, D.; De Luca, C.; Iafisco, M.
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 1-gen-2021 Colombo, Paolo; Quarta, Eride; Colombo, Gaia; Banella, Sabrina
POWDER COMPOSITION BASED ON MICROPARTICLES EMBEDDING NANOPARTICLES FOR THE DELIVERY OF THERAPEUTIC/DIAGNOSTIC COMPOUNDS 1-gen-2021 Catalucci, Daniele; Iafisco, Michele; Colombo, Paolo; Quarta, Eride
Understanding the importance of capsules in dry powder inhalers 1-gen-2021 Buttini, F.; Quarta, E.; Allegrini, C.; Lavorini, F.
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 1-gen-2021 Stecanella, L. A.; Bitencourt, A. P. R.; Vaz, G. R.; Quarta, E.; Silva Junior, J. O. C.; Rossi, A.
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 1-gen-2021 Tiozzo Fasiolo, L.; Manniello, M. D.; Banella, S.; Napoli, L.; Bortolotti, F.; Quarta, E.; Colombo, P.; Balafas, E.; Kostomitsopoulos, N.; Rekkas, D. M.; Valsami, G.; Papakyriakopoulou, P.; Colombo, G.; Russo, P.
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 1-gen-2021 Quarta, E.; Sonvico, F.; Bettini, R.; De Luca, C.; Dotti, A.; Catalucci, D.; Iafisco, M.; Degli Esposti, L.; Colombo, G.; Trevisi, G.; Rekkas, D. M.; Rossi, A.; Wong, T. W.; Buttini, F.; Colombo, P.
Orphan Designation and Cisplatin/Hyaluronan Complex in an Intracavitary Film for Malignant Mesothelioma 1-gen-2021 Banella, Sabrina; Quarta, Eride; Colombo, Paolo; Sonvico, Fabio; Pagnoni, Antonella; Bortolotti, Fabrizio; Colombo, Gaia
Probing critical physical properties of lactose-polyethylene glycol microparticles in pulmonary delivery of chitosan nanoparticles 1-gen-2021 Alhajj, N.; Naharudin, I.; Colombo, P.; Quarta, E.; Wong, T. W.
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 1-gen-2021 Villetti, Marcos Antonio; Clementino, Adryana Rocha; Dotti, Ilaria; Ebani, Patricia Regina; Quarta, Eride; Buttini, Francesca; Sonvico, Fabio; Bianchera, Annalisa; Borsali, Redouane
Respicell(TM): An innovative dissolution apparatus for inhaled products 1-gen-2021 Sonvico, F.; Chierici, V.; Varacca, G.; Quarta, E.; D'Angelo, D.; Forbes, B.; Buttini, F.
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 1-gen-2022 Quarta, E.; Degli Esposti, L.; Bettini, R.; Sonvico, F.; Catalucci, D.; Iafisco, M.; De Luca, C.; Trevisi, G.; Colombo, P.; Rossi, A.; Buttini, F.; Colombo, G.
Recent Patents on Nasal Vaccines Containing Nanoadjuvants 1-gen-2022 Candela, F.; Quarta, E.; Buttini, F.; Ancona, A.; Bettini, R.; Sonvico, F.
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 1-gen-2023 D'Angelo, D; Chierici, V; Quarta, E; Varacca, G; Cavalieri, L; Piraino, A; Melani, As; Sonvico, F; Buttini, F
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 1-gen-2023 D'Angelo, Davide; Quarta, Eride; Glieca, Stefania; Varacca, Giada; Flammini, Lisa; Bertoni, Simona; Brandolini, Martina; Sambri, Vittorio; Grumiro, Laura; Gatti, Giulia; Dirani, Giorgio; Taddei, Francesca; Bianchera, Annalisa; Sonvico, Fabio; Bettini, Ruggero; Buttini, Francesca
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 1-gen-2023 Quarta, Eride; Chiappi, Michele; Adamiano, Alessio; Tampieri, Anna; Wang, Weijie; Tetley, Teresa D.; Buttini, Francesca; Sonvico, Fabio; Catalucci, Daniele; Colombo, Paolo; Iafisco, Michele; Degli Esposti, Lorenzo
Nasal delivery as a strategy for the prevention and treatment of COVID-19 1-gen-2023 Sonvico, Fabio; Colombo, Gaia; Quarta, Eride; Guareschi, Fabiola; Banella, Sabrina; Buttini, Francesca; Scherließ, Regina
Mostrati risultati da 1 a 20 di 26
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile